Weight Management
Cagrilintide
Long-acting amylin analogue for enhanced satiety, delayed gastric emptying, and appetite control.
About Cagrilintide
Cagrilintide is a novel, long-acting synthetic amylin analogue designed for metabolic support and chronic weight management. By acting on calcitonin and amylin receptors in the brain's appetite control centers, Cagrilintide promotes early satiety, prolongs fullness after meals, and works effectively on its own or synergistically in multi-target weight loss protocols.
Key Benefits
Potent Satiety Enhancement
Acts on central amylin receptors to signal profound post-meal fullness.
Delayed Gastric Emptying
Slows digestion to reduce postprandial glucose spikes and hunger.
Synergistic Weight Loss
Offers exceptional complementary efficacy alongside GLP-1 therapies.
Craving Reduction
Diminishes hedonic eating behaviors and cravings for calorie-dense foods.
Dosing Guide
Dosage1mg (Starting dose)
FrequencyOnce weekly (SubQ)
DurationOngoing maintenance protocol
Helpful Tips
- Inject subcutaneously once weekly on the same day, with or without meals.
- Begin at the starting dose (0.3mg) and titrate in 4-week increments to minimize nausea.
- Pair with balanced nutrition and consistent hydration for peak digestive comfort.